Newly Diagnosed: Treatment Strategies for Epidermolysis Bullosa
While epidermolysis bullosa (EB) has no cure, nor are any disease-modifying therapies approved yet, there are therapeutic approaches that can help to ease symptoms and improve quality of life. Several experimental treatments are also currently in clinical trials that could prove beneficial for EB patients. Check out the information below to explore more about therapeutic strategies your doctor may recommend and what therapies are in the pipeline for potential future use.
There is currently no cure for EB, and treatments focus on preventing blisters or managing the wounds caused by the condition. There are different types of EB that are associated with blisters forming in different locations on the body and that vary in severity. Different treatments are used depending on the type of epidermolysis bullosa.
The cause of EB is generally a mutation in a gene that produces essential skin proteins, resulting in a faulty protein, or none at all. Potential therapies are aimed at restoring this by supplying cells that have the correct gene to the body, inserting the correct gene, or directly supplying the correct protein.